Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

US FTC: 'Product-hopping' illegally impedes generic entry

The US Government is becoming increasingly critical of industry attempts to ward off competition through ‘product-hopping,’ an IP lawyer says.

Pfizer to pay for clean up

Latest job cuts leave MannKind a third smaller than in 2014, says CFO

MannKind has cut more jobs in efforts to streamline operations, leaving the inhalable insulin manufacturer around a third smaller than this time last year.

Growing demand for vegetarian capsules despite their cost, says Capsugel

Capsugel has seen growing pharma demand for vegetarian capsules with formulation benefits outweighing the fact they cost more than gelatin.

Conventional wisdom yields conventional outcomes, says 'Brilliant' drug delivery professor

In an exclusive Q&A, nanoparticle pioneer Kathryn Whitehead wishes industry would invest more in delivery vehicles and predicts Alnylam will be first to commercialise an siRNA therapeutic.

US FDA issues alert for sterile products made by Californian compounder

The US FDA has issued a product safety alert and recommended a compounding pharmacy cease manufacturing operations after observing unsanitary conditions at a Californian facility.


NHS rejects suggestion a lack of guidance has slowed biosimilar uptake

The NHS has rejected Napp Pharmaceuticals’ accusation it lacks biosimilar guidance, citing a recently published policy document.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...